FUCHS Pref.

Q4: low visibility on COVID-19 free outlook

20/03/20 -"While the results came in line with the preliminary update, the focal point was on the outlook. Management has not changed its tune and repeated its outlook prepared before COVID-19 became a ..."

PDF page sample
Pages
46
Language
English
Published on
20/03/20
Download
You may also be interested by these reports :
23/04/24
Akzo’s Q1 delivered a strong set of consensus-beating figures (sales: +1.9%; adjusted EBITDA: +4.3%; net profit: +23.4%). After all the past trouble ...
22/04/24
Downgrade to Add – New target price EUR 85
19/04/24
Disappointing on first sight, but well in-line with our investment case on second glance
16/04/24
Supporting fundamentals & no more Kottmann items

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO